M. Berrey
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
M.
Michelle Berrey is currently Director at The North Carolina Biotechnology Center, Director at Noveome Biotherapeutics, Inc. since 2020, Director at Virion Therapeutics LLC since 2021, and Independent Director at Ocean Biomedical Holdings, Inc. since 2021.
Former roles include Chief Executive Officer & Director at Ocean Biomedical, Inc. from 2024 to 2025, Chief Medical Officer & President-Research at Intercept Pharmaceuticals, Inc., President, Chief Executive & Medical Officer at Chimerix, Inc. from 2014 to 2019, Chief Medical Officer & VP-Clinical Development at Pharmasset, Inc. from 2007 to 2012, and VP-Viral Diseases & Clinical Pharmacology at GSK Plc from 2004 to 2007.
Education includes undergraduate and graduate degrees from Emory University and a doctorate from Georgia Health Sciences University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-02-20 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Director/Board Member | - |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Director/Board Member | 2020-10-21 |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2021-02-28 |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Director/Board Member | 2021-07-11 |
| Companies | Position | End |
|---|---|---|
| OCEAN BIOMEDICAL, INC. | Chief Executive Officer | 2025-03-27 |
| CHIMERIX, INC. | Chief Executive Officer | 2019-02-04 |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Chief Tech/Sci/R&D Officer | 2012-01-12 |
| GSK PLC | Corporate Officer/Principal | 2006-12-31 |
| INTERCEPT PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 11 |
|---|---|
Chimerix, Inc.
Chimerix, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines for rare epilepsies, cancers and sleep disorders | Health Technology |
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Develops drugs to treat viral infections | Health Technology |
Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Emory University
Emory University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgia Health Sciences University
Georgia Health Sciences University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The North Carolina Biotechnology Center
The North Carolina Biotechnology Center Internet Software/ServicesTechnology Services Provides research and education grants | Technology Services |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures regenerative medicines | Health Technology |
Virion Therapeutics LLC
Virion Therapeutics LLC BiotechnologyHealth Technology Develops chronic viral disease vaccines | Health Technology |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ocean Biomedical, Inc.
Ocean Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Select your edition
All financial news and data tailored to specific country editions